FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1178-1179 October 19, 2000 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Langer, O. PubMed Citation

Gestational diabetes mellitus has been a contentious subject since it was first described. From a global perspective, authors have questioned its very existence, the burden of morbidity that it causes, and whether making the diagnosis simply increases the expense and complexity of perinatal care. Arguments have raged over who should be tested for gestational diabetes, when during pregnancy the testing should be done, what results define the disorder, and how affected women should be treated. For those willing to acknowledge that moderate abnormalities in carbohydrate metabolism during pregnancy require attention, there has been one point of agreement: if diet and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Langer, O. (2007). Oral Antidiabetic Drugs in Pregnancy: The Other Alternative. Diabetes Spectr. 20: 101-105 [Abstract] [Full Text]  
• (2000). Glyburide Is Effective in Women with Gestational Diabetes. JWatch General 2000: 2-2 [Full Text]